Medicure (MCUJF) Revenue Growth (3y) (2012 - 2026)
Medicure (MCUJF) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 2.94% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 11.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.66% |
| Dec 31, 2025 | 9.61% |
| Sep 30, 2025 | -22.71% |
| Jun 30, 2025 | -18.80% |
| Sep 30, 2024 | -31.73% |
| Jun 30, 2024 | -3.00% |
| Mar 31, 2024 | 2.71% |
| Dec 31, 2023 | 36.55% |
| Sep 30, 2023 | 11.89% |
| Jun 30, 2023 | 32.22% |
| Mar 31, 2023 | 22.85% |
| Dec 31, 2022 | 20.93% |
| Sep 30, 2022 | 45.36% |
| Jun 30, 2022 | 24.05% |
| Sep 30, 2021 | 28.28% |
| Jun 30, 2021 | -11.88% |
| Mar 31, 2021 | -6.68% |
| Dec 31, 2020 | -22.79% |
| Sep 30, 2020 | -46.00% |
| Jun 30, 2020 | -44.50% |